Role of poly(ADP-ribose) glycohydrolase in the development of inflammatory bowel disease in mice

Free Radical Biology and Medicine

Volumn 42, Issue 1, 2007, Pages 90-105

  Cuzzocrea, Salvatore ^a,b   Mazzon, Emanuela ^a,b   Genovese, Tiziana ^a   Crisafulli, Concetta ^a   Min, Woo Kee ^c   Di Paola, Rosanna ^a   Muià, Carmelo ^a   Li, Jia He ^d   Malleo, Giuseppe ^a   Xu, Weizhen ^a   Massuda, Edmond ^e   Esposito, Emanuela ^f   Zhang, Jie ^d   Wang, Zhao Qi ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d GUILFORD PHARMACEUTICALS INC   (United States)

^e Lilium Pharmaceuticals   (United States)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Apoptosis; Colitis; IL 1 ; Inflammation; PARG inhibitor; PARG110 deletion; TNF

Indexed keywords

FAS LIGAND; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; NITROBENZENE DERIVATIVE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); POLY(ADENOSINE DIPHOSPHATE RIBOSE) GLYCOSIDASE; SULFONIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON INJURY; ENTERITIS; ENZYME ACTIVITY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STAINING;

ANIMALS; BENZENESULFONATES; CELL DEATH; COLITIS; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; GLYCOSIDE HYDROLASES; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-1BETA; MICE; PEROXIDASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33751514961     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.09.025     Document Type: Article

References (56)

1. Cuzzocrea S. Emerging biotherapies for inflammatory bowel disease. Expert Opin. Emerg. Drugs 8 (2003) 339-347
2. Elson C.O. Experimental models of intestinal inflammation: new insights into mechanisms of mucosal homeostasis. In: Ogro P.L., Lamm M.E., Bienenstock J., Mestecky J., Strober W., and McGhee J.R. (Eds). Mucosal immunology (1999), Academic Press, San Diego 1007-1024
3. Snapper S.B., Rosen F.S., Mizoguchi E., et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 9 (1998) 81-91
4. Matsumoto S., Okabe Y., Setoyama H., et al. Inflammatory bowel disease-like enteritis caecitis in a senescence accelerated mouse P1/Yit strain. Gut 43 (1998) 71-78
5. Blumberg R.S., Saubermann L.J., and Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol. 11 (1999) 648-656
6. Cuzzocrea S., McDonald M.C., Mazzon E., et al. The tyrosine kinase inhibitor tyrphostin AG 126 reduced the development of colitis in the rat. Lab. Invest. 80 (2000) 1439-1453
7. Mazzon E., Puzzolo D., Caputi A.P., et al. Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis. Mol. Med. 8 (2002) 353-366
8. Desreumaux P., Brandt E., Gambiez L., Emilie D., Geboes K., Klein O., Ectors N., Cortot A., Capron M., and Colombel J.F. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology 113 (1997) 118-126
9. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76 (1994) 301-314
10. Picarella D., Hurlbut P., Rottman J., Shi X., Butcher E., and Ringler D.J. Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells. J. Immunol. 158 (1997) 2099-2106
11. Kitahara T., Suzuki K., Asakura H., Yoshida T., Suematsu M., Watanabe M., Aiso S., and Tsuchiya M. Active oxygen species generated monocytes and polymorphnuclear cells in Crohn's disease. Dig. Dis. Sci. 33 (1988) 951-955
12. Crama-Bohbouth G.E., Arndt J.W., Pena A.S., Verspaget H.W., Tjon A., Tham R.T., Weterman I.T., Pauwels E.K., and Lamers C.B. Value of indium-111 granulocyte scintigraphy in the assessment of Crohn's disease of the small intestine: prospective investigation. Digestion 40 (1988) 227-236
13. Cuzzocrea S., Riley D.P., Caputi A.P., and Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 53 (2001) 135-159
14. Berger N.A. Poly(ADP-ribose) in the cellular response to DNA damage. Radiat. Res. 101 (1985) 4-15
15. Schraufstatter I.U., Hyslop P.A., Hinshaw D.B., Spragg R.G., Sklar L.A., and Cochrane C.G. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA 83 (1986) 4908-4912
16. Piela-Smith T.H., Aune T., Aneiro L., Nuveen E., and Korn J.H. Impairment of lymphocyte adhesion to cultured fibroblasts and endothelial cells by gamma-irradiation. J. Immunol. 148 (1992) 41-46
17. Szabo C., and Dawson V.L. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol. Sci. 19 (1998) 287-298
18. Ha H.C., and Snyder S.H. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl. Acad. Sci. USA 96 (1999) 13978-13982
19. Lu X.C., Massuda E., Lin Q., Li W., Li J.H., and Zhang J. Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat. Brain Res. 978 (2003) 99-103
20. Slama J.T., Aboul-Ela N., Goli D.M., Cheesman B.V., Simmons A.M., and Jacobson M.K. Specific inhibition of poly(ADP-ribose) glycohydrolase by adenosine diphosphate (hydroxymethyl)pyrrolidinediol. J. Med. Chem. 38 (1995) 389-393
21. Ying W., and Swanson R.A. The poly(ADP-ribose) glycohydrolase inhibitor gallotannin blocks oxidative astrocyte death. Neuroreport 11 (2000) 1385-1388
22. Li, J.; Ferraris, D. V.; Kletzly, P. W.; et al. Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly(ADP-ribose) glycohydrolase, and methods for their use. US Patent 6:635--786.
23. Cuzzocrea S., and Wang Z.Q. Role of poly(ADP-ribose) glycohydrolase (PARG) in shock, ischemia and reperfusion. Pharmacol. Res. 52 (2005) 100-108
24. Genovese T., Di Paola R., Catalano P., Li J.H., Xu W., Massuda E., Caputi A.P., Zhang J., and Cuzzocrea S. Treatment with a novel poly(adp-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice. Crit. Care Med. 32 (2004) 1365-1374
25. Zhang J., and Li J. PARP and PARG as novel therapeutic targets. Drugs Fut. 27 (2002) 371-383
26. Cortes U., Tong W.M., Coyle D.L., Meyer-Ficca M.L., Meyer R.G., Petrilli V., Herceg Z., Jacobson E.L., Jacobson M.K., and Wang Z.Q. Depletion of the 110-kilodalton isoform of poly(ADP-Ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice. Mol. Cell. Biol. 16 (2004) 7163-7178
27. Cuzzocrea S., Di Paola R., Mazzon E., Cortes U., Genovese T., Muia C., Li W., Xu W., Li J.H., Zhang J., and Wang Z.Q. PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion. FASEB J. 19 (2005) 558-566
28. Patel N.S., Cortes U., Di Paola R., Mazzon E., Mota-Filipe H., Cuzzocrea S., Wang Z.Q., and Thiemermann C. Mice lacking the 110-kD isoform of poly(ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury. J. Am. Soc. Nephrol. 16 (2005) 712-719
29. Mazzon E., Dugo L., Li J.H., Di Paola R., Genovese T., Caputi A.P., Zhang J., and Cuzzocrea S. GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat. Biochem. Pharmacol. 64 (2002) 327-337
30. Lora L., Mazzon E., Billington D., Milanesi C., Naccarato R., and Martines D. Effects of cyclosporin A on paracellular and transcellular transport of horseradish peroxidase in perfused rat livers. Dig. Dis. Sci. 42 (1997) 514-521
31. Mullane K.M., Kraemer R., and Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J. Pharmacol. Methods 14 (1985) 157-167
32. Diaz-Granados N., Howe K., Lu J., and McKay D.M. Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity. Am. J. Pathol. 156 (2000) 2169-2177
33. Burkle A. Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays 23 (2001) 795-806
34. Di Meglio S., Denegri M., Vallefuoco S., Tramontano F., Scovassi A.I., and Quesada P. Poly(ADPR) polymerase-1 and poly(ADPR) glycohydrolase level and distribution in differentiating rat germinal cells. Mol. Cell. Biochem. 248 (2003) 85-91
35. Ying W., Sevigny M.B., Chen Y., and Swanson R.A. Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death. Proc. Natl. Acad. Sci. USA 98 (2001) 12227-12232
36. Zingarelli B., Szabo C., and Salzman A.L. Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis. Gastroenterology 116 (1999) 335-345
37. Szabo C., and Dawson V.L. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol. Sci. 19 (1998) 287-298
38. Ha H.C., and Snyder S.H. Poly (ADP-ribose) polymerase-1 in the nervous system. Neurobiol. Dis. 7 (2000) 225-239
39. Skaper S.D. Poly(ADP-ribosyl)ation enzyme-1 as a target for neuroprotection in acute central nervous system injury. Curr. Drug Targets CNS Neurol. Disord. 2 (2003) 279-291
40. Cozzi A., Cipriani G., Fossati S., Faraco G., Formentini L., Min W., Cortes U., Wang Z.Q., Moroni F., and Chiarugi A. Poly(ADP-ribose) accumulation and enhancement of postischemic brain damage in 110-kDa poly(ADP-ribose) glycohydrolase null mice. J. Cereb. Blood Flow Metab. 26 (2006) 684-695
41. Davidovich L., Vodenicharov M., Affar E.B., and Poirier G.G. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Exp. Cell Res. 268 (2001) 7-13
42. Rouleau M., Aubin R.A., and Poirier G.G. Poly(ADPribosyl)ated chromatin domains: access granted. J. Cell. Sci. 117 (2004) 815-825
43. Virag L. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Curr. Vasc. Pharmacol. 3 (2005) 209-214
44. Carty E., De Brabander M., Feakins R.M., and Rampton D.S. Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper. Gut 46 (2000) 487-492
45. Hassa P.O., Haenni S.S., Buerki C., Meier N.I., Lane W.S., Owen H., Gersbach M., Imhof R., and Hottiger M.O. Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J. Biol. Chem. 280 (2005) 40450-40464
46. Kadl A., and Leitinger N. The role of endothelial cells in the resolution of acute inflammation. Antioxid. Redox Signal. 7 (2005) 1744-1754
47. Farhood A., McGuire G.M., and Manning A.M. Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J. Leukoc. Biol. 57 (1995) 368-374
48. Hawkins H.K., Entman M.L., and Zhu J.Y. Acute inflammatory reaction after myocardial ischemic injury and reperfusion. Development and use of a neutrophil-specific antibody. Am. J. Pathol. 148 (1996) 1957-1969
49. Carlson S.L., Parrish M.E., Springer J.E., Doty K., and Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp. Neurol. 151 (1998) 77-88
50. Chatham W.W., Swaim R., Frohsin Jr. H., Heck L.W., Miller E.J., and Blackburn Jr. W.D. Degradation of human articular cartilage by neutrophils in synovial fluid. Arth. Rheum. 36 (1993) 51-58
51. Strater J., Wellisch I., Riedl S., Walczak H., Koretz K., Tandara A., Krammer P.H., and Moller P. CD95 (APO-1/Fas) -mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 113 (1997) 160-167
52. Iwamoto M., Koji T., Makiyama K., Kobayashi N., and Nakane P.K. Apoptosis of crypt epithelial cells in ulcerative colitis. J. Pathol. 180 (1996) 152-159
53. Bu P., Keshavarzian A., Stone D.D., Liu J., Le P.T., Fisher S., and Qiao L. Apoptosis: one of the mechanisms that maintains unresponsiveness of the intestinal mucosal immune system. J. Immunol. 166 (2001) 6399-6403
54. Bregenholt S., Petersen T.R., and Claesson M.H. The majority of lamina propria CD4- T-cells from SCID mice with colitis undergoe Fas-mediated apoptosis in vivo. Immunol. Lett. 78 (2001) 7-12
55. Siegel R.M., Chan F.K., Chun H.J., and Lenardo M.J. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 1 (2000) 469-474
56. Lu B., Wang L., Medan D., Toledo D., Huang C., Chen F., Shi X., and Rojanasakul Y. Regulation of Fas (CD95)-induced apoptosis by nuclear factor-kB and tumor necrosis factor-α in macrophages. Am. J. Physiol. Cell Physiol. 283 (2002) C831-C838